Skip to main content
MEDICA GROUP PLC logo

MEDICA GROUP PLC — Investor Relations & Filings

Ticker · MGPM ISIN · GB00BYV24996 LEI · 213800B8XE5FUSZF5Z16 IL Human health and social work activities
Open in API
Filings indexed 343 across all filing types
Latest filing 2023-07-07 Delisting Announcement
Country GB United Kingdom
Listing IL MGPM

About MEDICA GROUP PLC

https://medica.co.uk/

Medica Group PLC is a provider of telemedicine services, specializing in teleradiology and telepathology. The company partners with healthcare organizations, including NHS Trusts and independent sector providers, to deliver outsourced interpretation and reporting of diagnostic imaging and pathology samples. Leveraging a global network of specialist radiologists and pathologists, Medica provides fast, quality-assured reporting services designed to shorten patient wait times and enhance clinical workflows. Its offerings cover a wide range of needs, from routine elective procedures to urgent and specialized areas such as stroke, major trauma, musculoskeletal (MSK), and PET-CT imaging.

Recent filings

Filing Released Lang Actions
De-listing and Cancellation of Trading of Shares
Delisting Announcement Classification · 99% confidence The document begins with 'RNS Number' and is clearly formatted as a regulatory announcement distributed via RNS, the London Stock Exchange's news service. The content discusses a 'RECOMMENDED CASH ACQUISITION' and specifically announces the 'De-listing and Cancellation of Trading of Medica Shares' effective on July 7, 2023. This is a specific corporate action announcement related to the cessation of public trading, which is a type of regulatory event. While it relates to a takeover (TAR), the primary action being announced here is the delisting/cancellation of trading. The definition for Delisting Announcement (DLST) is 'Official notice that the company's stock will be removed from an exchange.' This fits the content perfectly. Although it is distributed via RNS, DLST is a more specific classification than the general RNS fallback.
2023-07-07 English
Form 8.3 - Medica Group plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is used to disclose dealings or positions related to a takeover offer. This type of disclosure, concerning insider transactions or significant holdings during a takeover scenario, is a specific type of regulatory filing related to insider activity, but more specifically, it relates to director/insider dealings in the context of a takeover. While 'DIRS' covers general director dealings, this specific form (Form 8.3) is highly specialized for takeover situations. However, among the provided codes, the closest fit for reporting personal share transactions by executives/insiders is 'DIRS' (Director's Dealing). Given the context of the Takeover Code and dealing disclosure, 'DIRS' is the most appropriate category for insider transaction reporting, even though it's specifically related to a takeover bid, which often falls under general regulatory disclosures if a more specific code isn't available. Since there is no specific 'Takeover Disclosure' code, and it details dealings by a person with interests (Millennium International Management LP) in the relevant securities, DIRS is the best fit among the options for insider transaction reporting.
2023-07-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is explicitly labeled with "RNS Number" and contains a standard form titled "TR-1: Standard form for notification of major holdings". This form details changes in voting rights held by an entity (Samson Rock Capital LLP) in the issuer (Medica Group PLC), crossing a notification threshold. This type of mandatory disclosure regarding significant share ownership changes is a specific regulatory filing. While it is a regulatory filing, the specific nature of reporting major shareholdings aligns best with the category for significant shareholding notifications, which is 'MRQ' (Major Shareholding Notification) in the provided definitions, as it deals with changes in ownership thresholds. However, since the document is clearly an RNS announcement containing a regulatory form (TR-1), and 'MRQ' is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)', MRQ is the most precise fit. The presence of the RNS header and footer confirms it is distributed via the Regulatory News Service.
2023-07-06 English
Scheme of Arrangement becomes Effective
Regulatory Filings Classification · 98% confidence The document is a formal announcement dated 06 July 2023, originating from the 'National Storage Mechanism' and bearing an 'RNS Number'. The content explicitly discusses a 'RECOMMENDED CASH ACQUISITION' of Medica Group PLC by Moonlight Bidco Limited, referencing the 'Scheme of Arrangement' under Part 26 of the Companies Act 2006, the 'Scheme Document', and the subsequent 'Completion of Recommended Offer'. It also details the suspension of trading and cancellation of admission to trading of Medica Shares. The presence of an RNS Number, the formal structure, and the subject matter (takeover/acquisition completion) strongly indicate this is a regulatory news service announcement. Since the document is an announcement about a major corporate action (takeover completion) and is distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory disclosure that doesn't fit the more specific categories like Director's Dealing (DIRS) or Capital Change (SHA). Although it relates to M&A (TAR), RNS is the standard category for these types of immediate regulatory updates distributed through the service.
2023-07-06 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document begins with 'RNS Number : 0950F' and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange. The content details share transactions (vesting and exercise of options) by Persons Discharging Managerial Responsibilities (PDMRs) and includes required regulatory disclosures under UK Market Abuse Regulation. This type of mandatory disclosure regarding insider transactions by directors/executives falls under the category of Director's Dealing (DIRS). Although it is an RNS filing, DIRS is a more specific and appropriate classification than the general RNS fallback.
2023-07-05 English
Form 8.3 - Medica Group plc
Major Shareholding Notification Classification · 97% confidence The document is explicitly titled "FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" and references "Rule 8.3 of the Takeover Code (the “Code”)". This type of filing relates to disclosures required by the UK Takeover Panel regarding interests in securities during an offer period. This specific disclosure concerns a significant shareholder's position and dealings related to an offer involving 'Medica Group plc'. This regulatory disclosure concerning insider/major shareholder dealings during a takeover context is best classified under Director's Dealing (DIRS) or, more broadly, as a specific regulatory filing. Given the options, 'Director's Dealing' (DIRS) covers personal share transactions by executives/directors, and while this is a major shareholder disclosure under the Takeover Code, it falls under the umbrella of insider/related party transaction reporting. However, since the definition for DIRS is strictly 'Report of personal share transactions by company directors and executives (insider trades)', and this is a Form 8.3 related to a takeover, it is a highly specific regulatory disclosure. Form 8.3 disclosures are mandatory filings related to takeover activity. Since there is no specific 'Takeover Disclosure' code, and it involves reporting interests/dealings by a significant party, it is closest to DIRS, but the most accurate general category for mandatory, specific regulatory reports not covered elsewhere is RNS. Upon review, Form 8.3 is a mandatory disclosure under the Takeover Code, which is a regulatory requirement. Since DIRS is narrowly defined for directors' personal trades, and this is a major shareholder disclosure during a potential offer, RNS (General regulatory announcements and fallback category) is the most appropriate fit among the provided codes for a specific, non-standard regulatory form like this, unless it is interpreted as an insider dealing report. Given the context of the Takeover Code, it is a mandatory regulatory filing. I will classify it as RNS as the best fit for a specific regulatory filing not covered by the other specific codes (like 10-K, ER, etc.).
2023-07-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.